← Back
CalciMedica
CALC · listed on Nasdaq · worth $9.97 million
$1.46
−16.57% on Oct 30
One insider buy in the last year, $200K in all. None in the last two weeks.
Green dot = an insider bought◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
Reverse split 1-for-5 in Aug 2026. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what CALC ever actually traded at. The drop is real, but those huge old numbers aren't.
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
3.8M shares
55% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, one insider bought CalciMedica stock and none sold.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
10% owner
Fred A. Middleton
Bought $200K on Jun 25 — 248,972 shares at $0.8033, held through a trust or family, 23% of what they now own.
First purchase we have on file
Big investors
People and funds that reported owning 5% or more of CalciMedica, newest first.
Filed by someone who owns 5% or more and does not plan to influence the company.Stonepine Capital Management6.0%Aug 25
Filed by someone who owns 5% or more and may try to influence how the company is run. · updateAlafi Capital Co LLC19.9%Aug 24Reported stake, oldest first: 17.1% (Jul 10) → 19.9% (Aug 24)
Filed by someone who owns 5% or more and may try to influence how the company is run. · updateBering Partners II GP10.0%Aug 21Reported stake, oldest first: 6.9% (Jul 2) → 9.99% (Aug 21)
Filed by someone who owns 5% or more and does not plan to influence the company.Woodline Partners LP8.1%Aug 14
Filed by someone who owns 5% or more and does not plan to influence the company.Armistice Capital10.0%Aug 14
Each history starts at the oldest report we hold.
All reports
Every insider trade and SEC report we hold for CalciMedica.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Jun 29BoughtFred A. MiddletonJun 29 · Traded Jun 25 · 10% owner+23%via a trust or family248,972 @ $0.8033$200K
Sep 22, 2025BoughtEric W. Roberts10%Sep 22, 2025 · Traded Sep 18, 2025 · CHIEF BUSINESS OFFICER+3.0%via a trust or family2,500 @ $3.07$7.7K
Sep 17, 2025BoughtEric W. Roberts10%Sep 17, 2025 · Traded Sep 15, 2025 · CHIEF BUSINESS OFFICER+4.2%via a trust or family3,400 @ $2.68$9.1K
Sep 15, 2025BoughtEric W. Roberts10%Sep 15, 2025 · Traded Sep 12, 2025 · CHIEF BUSINESS OFFICER+6.4%via a trust or family5,000 @ $3.12$15.6K
Sep 11, 2025BoughtEric W. Roberts10%Sep 11, 2025 · Traded Sep 9, 2025 · CHIEF BUSINESS OFFICER+3.2%via a trust or family2,343 @ $3.15$7.4K
26 more with Pro →Analysts, earnings and news
Analysts' price target
$10.33 average
3 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
1 of 4 quarters above
Q2 '26−$2.25 a share−$0.80
Q1 '26$1.50 a share+$2.90
Q4 '25−$3.45 a share−$1.39
Q3 '25−$2.60 a share−$0.54